Physician profile
Torre Morgan
NPI 1851382360
$4,352.58
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,607 · 2020: $614 · 2021: $1,561 · 2022: $290 · 2023: $232 · 2024: $49.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.82 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $917.10 | 2019-2022 | |
| Abbvie INC. | $796.53 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $627.15 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $571.80 | 2019-2021 | |
| Janssen Biotech, INC. | $496.19 | 2019-2023 | Stelara |
| Pfizer INC. | $257.32 | 2019-2024 | |
| Gilead Sciences, INC. | $156.73 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $85.77 | 2019-2021 | |
| Celgene Corporation | $81.51 | 2021 | |
| Ferring Pharmaceuticals INC. | $73.28 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $61.55 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $41.32 | 2021-2022 | |
| Ucb, INC. | $29.56 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $28.19 | 2023 | |
| Qol Medical, LLC | $24.36 | 2023 | Sucraid |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $21.09 | 2021 | |
| Alfasigma USA, INC. | $19.03 | 2020 | |
| Allergan, INC. | $18.92 | 2019 | |
| Shire North American Group INC | $17.47 | 2019 | |
| Covidien Lp | $16.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torre Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.